<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=1851861" created="20/02/2006" creator="Hitomi MASUDA"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>1851861</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Transactivation of the <term id="T1" lex="human_immunodeficiency_virus_promoter" sem="DNA_domain_or_region"><term id="T2" lex="human_immunodeficiency_virus" sem="Virus">human immunodeficiency virus</term> promoter</term> by <cons id="T3" lex="(AND human_herpesvirus_6_(HHV-6)_strain_GS human_herpesvirus_6_(HHV-6)_strain_Z-29)" sem="(AND Virus Virus)"><frag id="F1"><term id="T4" lex="human_herpesvirus_6" sem="Virus">human herpesvirus 6</term> (<term id="T5" lex="HHV-6" sem="Virus">HHV-6</term>) strains</frag> <frag id="F2"><term id="A1" sem="Virus">GS</term></frag> and <frag id="F3"><term id="A2" sem="Virus">Z-29</term></frag></cons> in <term id="T6" lex="primary_human_T_lymphocyte" sem="Cell_natural">primary human T <term id="T7" lex="lymphocyte" sem="Cell_natural">lymphocytes</term></term> and identification of <term id="T8" lex="transactivating_HHV-6(GS)_gene_fragment" sem="DNA_family_or_group"><term id="T9" lex="transactivating_HHV-6" sem="Virus">transactivating HHV-6</term>(GS) gene fragments</term>.</sentence>
<event id="E1">
<type class="Positive_regulation"/>
<theme idref="T1"/>
<cause idref="A1"/>
<clue><clueType>Transactivation</clueType> <linkTheme>of</linkTheme> the human immunodeficiency virus promoter <linkCause>by</linkCause> human herpesvirus 6 (HHV-6) strains GS and Z-29 <clueLoc>in primary human T lymphocytes</clueLoc> and identification of transactivating HHV-6(GS) gene fragments.</clue>
</event>
<event id="E2">
<type class="Positive_regulation"/>
<theme idref="T1"/>
<cause idref="A2"/>
<clue><clueType>Transactivation</clueType> <linkTheme>of</linkTheme> the human immunodeficiency virus promoter <linkCause>by</linkCause> human herpesvirus 6 (HHV-6) strains GS and Z-29 <clueLoc>in primary human T lymphocytes</clueLoc> and identification of transactivating HHV-6(GS) gene fragments.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T10" lex="human_herpesvirus_6" sem="Virus">Human herpesvirus 6</term> (<term id="T11" lex="HHV-6" sem="Virus">HHV-6</term>) can activate the <term id="T12" lex="human_immunodeficiency_virus_(HIV)_promoter" sem="DNA_domain_or_region"><term id="T13" lex="human_immunodeficiency_virus" sem="Virus">human immunodeficiency virus</term> (<term id="A100" sem="Virus">HIV</term>) <term id="A101" sem="DNA_domain_or_region">promoter</term></term> and accelerate <term id="A3" sem="Other">cytopathic effects</term> in <term id="T14" lex="HIV-infected_human_T_cell" sem="Cell_natural"><term id="A61" sem="Virus">HIV</term>-infected <term id="A60" sem="Cell_natural">human T cells</term></term>.</sentence>
<event KT="Fact" id="E3">
<type class="Positive_regulation"/>
<theme idref="A100" idref1="A101"/>
<cause idref="T11"/>
<clue>Human herpesvirus 6 (HHV-6) can <clueType>activate</clueType> the human immunodeficiency virus (HIV) promoter and accelerate cytopathic effects in HIV-infected human T cells.</clue>
</event>
<event KT="Fact" id="E6">
<type class="Positive_regulation"/>
<theme idref="A3"/>
<cause idref="T11"/>
<clue>Human herpesvirus 6 (HHV-6) can activate the human immunodeficiency virus (HIV) promoter and <clueType>accelerate</clueType> cytopathic effects <clueLoc>in HIV-infected human T cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E106">
<type class="Initiation_of_viral_infection"/>
<theme idref="A60"/>
<theme idref="A61"/>
<clue>Human herpesvirus 6 (HHV-6) can activate the human immunodeficiency virus (HIV) promoter and accelerate cytopathic effects in HIV-<clueType>infected</clueType> human T cells.</clue>
</event>
<sentence id="S3">This study examines the regions of the <term id="T15" lex="HIV_promoter" sem="DNA_domain_or_region">HIV promoter</term> required for <term id="T16" lex="HHV-6_transactivation" sem="Other"><term id="T17" lex="HHV-6" sem="Virus">HHV-6</term> transactivation</term> in a heterogeneous population of <term id="T18" lex="primary_human_T_lymphocyte" sem="Cell_natural">primary human T lymphocytes</term> with or without <term id="T19" lex="antigenic_stimulation" sem="Other">antigenic stimulation</term>.</sentence>
<event KT="Other" id="E7">
<type class="Positive_regulation"/>
<theme idref="T17"/>
<clue>This study examines the regions of the HIV promoter required for HHV-6 <clueType>transactivation</clueType> in a heterogeneous population of primary human T lymphocytes with or without antigenic stimulation.</clue>
</event>
<event KT="Investigation" id="E8" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E7"/>
<cause idref="T15"/>
<cause idref="T19"/>
<clue>This study <clueKT>examines</clueKT> the regions of the HIV promoter <clueType>required</clueType> <linkTheme>for</linkTheme> HHV-6 transactivation <clueLoc>in a heterogeneous population of primary human T lymphocytes</clueLoc> <corefCause>with</corefCause> or without antigenic stimulation.</clue>
</event>
<event KT="Investigation" id="E9" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E7"/>
<cause idref="T15"/>
<clue>This study <clueKT>examines</clueKT> the regions of the HIV promoter <clueType>required</clueType> <linkTheme>for</linkTheme> HHV-6 transactivation <clueLoc>in a heterogeneous population of primary human T lymphocytes</clueLoc> with or without antigenic stimulation.</clue>
</event>
<sentence id="S4">Two different strains of <term id="T20" lex="HHV-6" sem="Virus">HHV-6</term>, <term id="T21" lex="GS" sem="Virus">GS</term> and <term id="T22" lex="Z29" sem="Virus">Z29</term>, transactivated the <term id="T23" lex="HIV_promoter" sem="DNA_domain_or_region">HIV promoter</term>.</sentence>
<event id="E10">
<type class="Positive_regulation"/>
<theme idref="T23"/>
<cause idref="T21"/>
<clue>Two different strains of HHV-6, GS and Z29, <clueType>transactivated</clueType> the HIV promoter.</clue>
</event>
<event id="E11">
<type class="Positive_regulation"/>
<theme idref="T23"/>
<cause idref="T22"/>
<clue>Two different strains of HHV-6, GS and Z29, <clueType>transactivated</clueType> the HIV promoter.</clue>
</event>
<sentence id="S5">The <term id="T24" lex="GS_strain" sem="Virus">GS strain</term> transactivated the <term id="T25" lex="promoter" sem="DNA_domain_or_region">promoter</term> in both stimulated and resting <term id="T26" lex="T_cell" sem="Cell_natural">T cells</term>, while the <term id="T27" lex="Z29_strain" sem="Virus">Z29 strain</term> increased <term id="T28" lex="HIV_promoter_activity" sem="Other"><term id="T29" lex="HIV_promoter" sem="DNA_domain_or_region">HIV promoter</term> activity</term> only in <term id="T30" lex="stimulated_T_cell" sem="Cell_natural">stimulated <term id="A62" sem="Cell_natural">T cells</term></term>.</sentence>
<event id="E12">
<type class="Positive_regulation"/>
<theme idref="T25"/>
<cause idref="T24"/>
<clue>The GS strain <clueType>transactivated</clueType> the promoter <clueLoc>in</clueLoc> both <clueLoc>stimulated</clueLoc> and resting <clueLoc>T cells</clueLoc>, while the Z29 strain increased HIV promoter activity only in stimulated T cells.</clue>
</event>
<event id="E212">
<type class="Positive_regulation"/>
<theme idref="T25"/>
<cause idref="T24"/>
<clue>The GS strain <clueType>transactivated</clueType> the promoter <clueLoc>in</clueLoc> both stimulated and <clueLoc>resting T cells</clueLoc>, while the Z29 strain increased HIV promoter activity only in stimulated T cells.</clue>
</event>
<event id="E112">
<type class="Physiological_process"/>
<theme idref="T26"/>
<clue>The GS strain transactivated the promoter in both <clueType>stimulated</clueType> and resting T cells, while the Z29 strain increased HIV promoter activity only in stimulated T cells.</clue>
</event>
<event id="E13">
<type class="Positive_regulation"/>
<theme idref="T28"/>
<cause idref="T27"/>
<clue>The GS strain transactivated the promoter in both stimulated and resting T cells, while the Z29 strain <clueType>increased</clueType> HIV promoter activity only <clueLoc>in stimulated T cells</clueLoc>.</clue>
</event>
<event id="E113">
<type class="Positive_regulation"/>
<theme idref="A62"/>
<clue>The GS strain transactivated the promoter in both stimulated and resting T cells, while the Z29 strain increased HIV promoter activity only in <clueType>stimulated</clueType> T cells.</clue>
</event>
<sentence id="S6"><term id="A63" sem="DNA_molecule">Three DNA clones containing <term id="T31" lex="HHV-6(GS)_genomic_fragment" sem="DNA_molecule">HHV-6(GS) genomic fragments</term></term> transactivated the <term id="T32" lex="HIV_promoter" sem="DNA_domain_or_region">HIV promoter</term> in <term id="T33" lex="cotransfected_T_cell" sem="Cell_cultured">cotransfected <term id="A64" sem="Cell_natural">T cells</term></term>.</sentence>
<event id="E14">
<type class="Positive_regulation"/>
<theme idref="T32"/>
<cause idref="T31"/>
<clue>Three DNA clones containing HHV-6(GS) genomic fragments <clueType>transactivated</clueType> the HIV promoter <clueLoc>in cotransfected T cells</clueLoc>.</clue>
</event>
<event KT="Method" id="E114">
<type class="Artificial_process"/>
<theme idref="A63"/>
<theme idref="A64"/>
<clue>Three DNA clones containing HHV-6(GS) genomic fragments transactivated the HIV promoter in <clueType>cotransfected</clueType> T cells.</clue>
</event>
<sentence id="S7">A <term id="T34" lex="21.4-kb_DNA_clone" sem="DNA_molecule">21.4-kb DNA clone</term>, <term id="T35" lex="pZVB70" sem="DNA_molecule">pZVB70</term>, showed the highest <term id="T36" lex="transactivating_ability" sem="Other">transactivating ability</term>, while two other <term id="T37" lex="DNA_fragments" sem="DNA_molecule">DNA fragments</term>, <term id="T38" lex="pZVB10" sem="DNA_molecule">pZVB10</term> (6.2 kb) and <term id="T39" lex="pZVH14" sem="DNA_molecule">pZVH14</term> (8.7 kb), showed lower activity.</sentence>
<event KT="Analysis" Manner="High" id="E15">
<type class="Positive_regulation"/>
<theme idref="T32"/>
<cause idref="T35"/>
<clue>A 21.4-kb DNA clone, pZVB70, <clueType><clueKT>showed</clueKT></clueType> the <clueManner>highest</clueManner> <clueType>transactivating ability</clueType>, while two other DNA fragments, pZVB10 (6.2 kb) and pZVH14 (8.7 kb), showed lower activity.</clue>
<comment>NO COREFTHEME</comment></event>
<event KT="Analysis" id="E16">
<type class="Positive_regulation"/>
<theme idref="T32"/>
<cause idref="T38"/>
<clue>A 21.4-kb DNA clone, pZVB70, showed the highest transactivating ability, while two other DNA fragments, pZVB10 (6.2 kb) and pZVH14 (8.7 kb), <clueType><clueKT>showed</clueKT></clueType> lower <clueType>activity</clueType>.</clue>
<comment>NO COREFETHEME</comment></event>
<event KT="Analysis" id="E17">
<type class="Positive_regulation"/>
<theme idref="T32"/>
<cause idref="T39"/>
<clue>A 21.4-kb DNA clone, pZVB70, showed the highest transactivating ability, while two other DNA fragments, pZVB10 (6.2 kb) and pZVH14 (8.7 kb), <clueType><clueKT>showed</clueKT></clueType> lower <clueType>activity</clueType>.</clue>
<comment>NO COREFETHEME</comment></event>
<sentence id="S8">One of these clones, <term id="T40" lex="pZVH14" sem="DNA_molecule">pZVH14</term>, activated the <term id="A7" sem="DNA_domain_or_region"><term id="T41" lex="HIV_promoter_construct" sem="DNA_molecule"><term id="T42" lex="HIV_promoter" sem="DNA_domain_or_region">HIV promoter</term> construct</term> containing a mutation in the <term id="T43" lex="NF_kappa_B_site" sem="DNA_molecule">NF kappa B site</term></term>.</sentence>
<event id="E19">
<type class="Positive_regulation"/>
<theme idref="A7"/>
<cause idref="T40"/>
<clue>One of these clones, pZVH14, <clueType>activated</clueType> the HIV promoter construct containing a mutation in the NF kappa B site.</clue>
<comment>TPS: A7</comment></event>
<event KT="Method" id="E119">
<type class="Mutagenesis"/>
<theme idref="T43"/>
<clue>One of these clones, pZVH14, activated the HIV promoter construct containing a <clueType>mutation</clueType> <linkTheme>in</linkTheme> the NF kappa B site.</clue>
<comment>ARTIFICIAL</comment></event>
<sentence id="S9">However, this <term id="T44" lex="mutated_NF_kappa_B_promoter" sem="DNA_domain_or_region">mutated <term id="A65" sem="DNA_domain_or_region">NF kappa B promoter</term></term> was not transactivated during <term id="T45" lex="HHV-6(GS)_infection" sem="Other"><term id="T46" lex="HHV-6(GS)" sem="Virus">HHV-6(GS)</term> infection</term> or after cotransfection with <term id="T47" lex="pZVB70" sem="DNA_molecule">pZVB70</term> or <term id="T48" lex="pZVB10" sem="DNA_molecule">pZVB10</term>.</sentence>
<event id="E20">
<type class="Initiation_of_viral_infection"/>
<theme idref="T46"/>
<clue>However, this mutated NF kappa B promoter was not transactivated during HHV-6(GS) <clueType>infection</clueType> or after cotransfection with pZVB70 or pZVB10.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E21">
<type class="Positive_regulation"/>
<theme idref="T44"/>
<cause idref="E20"/>
<clue>However, this mutated NF kappa B promoter was <cluePolarity>not</cluePolarity> <clueType>transactivated</clueType> <linkCause>during</linkCause> HHV-6(GS) infection or after cotransfection with pZVB70 or pZVB10.</clue>
</event>
<event KT="Method" id="E200">
<type class="Gene_expression"/>
<theme idref="T47"/>
<clue>However, this mutated NF kappa B promoter was not transactivated during HHV-6(GS) infection or after <clueType>cotransfection</clueType> <linkTheme>with</linkTheme> pZVB70 or pZVB10.</clue>
<comment>ARTIFICIAL</comment></event>
<event KT="Method" id="E201">
<type class="Positive_regulation"/>
<theme idref="E200"/>
<clue>However, this mutated NF kappa B promoter was not transactivated during HHV-6(GS) infection or after <clueType>cotransfection</clueType> with pZVB70 or pZVB10.</clue>
<comment>ARTIFICIAL</comment></event>
<event KT="Method" id="E202">
<type class="Gene_expression"/>
<theme idref="T48"/>
<clue>However, this mutated NF kappa B promoter was not transactivated during HHV-6(GS) infection or after <clueType>cotransfection</clueType> <linkTheme>with</linkTheme> pZVB70 or pZVB10.</clue>
<comment>ARTIFICIAL</comment></event>
<event KT="Method" id="E203">
<type class="Positive_regulation"/>
<theme idref="E202"/>
<clue>However, this mutated NF kappa B promoter was not transactivated during HHV-6(GS) infection or after <clueType>cotransfection</clueType> with pZVB70 or pZVB10.</clue>
<comment>ARTIFICIAL</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E22">
<type class="Positive_regulation"/>
<theme idref="T44"/>
<cause idref="E201"/>
<clue>However, this mutated NF kappa B promoter was <cluePolarity>not</cluePolarity> <clueType>transactivated</clueType> during HHV-6(GS) infection or <linkCause>after</linkCause> cotransfection with pZVB70 or pZVB10.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E23">
<type class="Positive_regulation"/>
<theme idref="T44"/>
<cause idref="E203"/>
<clue>However, this mutated NF kappa B promoter was <cluePolarity>not</cluePolarity> <clueType>transactivated</clueType> during HHV-6(GS) infection or <linkCause>after</linkCause> cotransfection with pZVB70 or pZVB10.</clue>
</event>
<event KT="Method" id="E123">
<type class="Mutagenesis"/>
<theme idref="A65"/>
<clue>However, this <clueType>mutated</clueType> NF kappa B promoter was not transactivated during HHV-6(GS) infection or after cotransfection with pZVB70 or pZVB10.</clue>
<comment>ARTIFICIAL</comment></event>
<sentence id="S10">These data indicate that the <term id="A400" sem="DNA_domain_or_region"><term id="T49" lex="NF_kappa_B_sites" sem="DNA_domain_or_region">NF kappa B sites</term> of the <term id="T50" lex="HIV_promoter" sem="DNA_domain_or_region">HIV promoter</term></term> are essential for its <term id="T51" lex="transactivation" sem="Other">transactivation</term> during <term id="T52" lex="HHV-6(GS)_infection" sem="Other"><term id="T53" lex="HHV-6(GS)" sem="Virus">HHV-6(GS)</term> infection</term>.</sentence>
<event id="E29">
<type class="Initiation_of_viral_infection"/>
<theme idref="T53"/>
<clue>These data indicate that the NF kappa B sites of the HIV promoter are essential for its transactivation during HHV-6(GS) <clueType>infection</clueType>.</clue>
</event>
<event KT="Other" id="E30">
<type class="Positive_regulation"/>
<theme idref="T50"/>
<cause idref="E29"/>
<clue>These data indicate that the NF kappa B sites of the HIV promoter are essential for <corefTheme>its</corefTheme> <clueType>transactivation</clueType> <linkCause>during</linkCause> HHV-6(GS) infection.</clue>
</event>
<event CL="L2" KT="Analysis" id="E31">
<type class="Positive_regulation"/>
<theme idref="E30"/>
<cause idref="A400"/>
<clue>These data <clueKT><clueCL>indicate</clueCL></clueKT> that the NF kappa B sites of the HIV promoter are <clueType>essential</clueType> <linkTheme>for</linkTheme> its transactivation during HHV-6(GS) infection.</clue>
<comment>TPS: A400</comment></event>
<sentence id="S11">By increasing <term id="T54" lex="HIV_promoter_activity" sem="Other"><term id="T55" lex="HIV_promoter" sem="DNA_domain_or_region">HIV promoter</term> activity</term> in <term id="T56" lex="primary_T_lymphocyte" sem="Cell_natural">primary T lymphocytes</term>, <term id="T57" lex="HHV-6" sem="Virus">HHV-6</term> may consequently increase <term id="T58" lex="HIV_replication" sem="Other"><term id="A5" sem="Virus">HIV</term> replication</term>, leading to an increase in the <term id="A6" sem="Other">cytopathic effect</term> on <term id="T59" lex="coinfected_human_T_cell" sem="Cell_natural">coinfected human T cells</term>.</sentence>
<event id="E24">
<type class="Positive_regulation"/>
<theme idref="T54"/>
<cause idref="T57"/>
<clue>By <clueType>increasing</clueType> HIV promoter activity <clueLoc>in primary T lymphocytes</clueLoc>, HHV-6 may consequently increase HIV replication, leading to an increase in the cytopathic effect on coinfected human T cells.</clue>
</event>
<event KT="Other" id="E25">
<type class="Viral_life_cycle"/>
<theme idref="A5"/>
<clue>By increasing HIV promoter activity in primary T lymphocytes, HHV-6 may consequently increase HIV <clueType>replication</clueType>, leading to an increase in the cytopathic effect on coinfected human T cells.</clue>
</event>
<event CL="L1" KT="Analysis" id="E26" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E25"/>
<cause idref="E24"/>
<clue><linkCause>By</linkCause> increasing HIV promoter activity in primary T lymphocytes, HHV-6 <clueCL>may</clueCL> <clueKT>consequently</clueKT> <clueType>increase</clueType> HIV replication, leading to an increase in the cytopathic effect on coinfected human T cells.</clue>
</event>
<event KT="Other" id="E27">
<type class="Positive_regulation"/>
<theme idref="A6"/>
<clue>By increasing HIV promoter activity in primary T lymphocytes, HHV-6 may consequently increase HIV replication, leading to an <clueType>increase</clueType> <linkTheme>in</linkTheme> the cytopathic effect <clueLoc>on coinfected human T cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E28" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E27"/>
<cause idref="E26"/>
<clue>By increasing HIV promoter activity in primary T lymphocytes, HHV-6 may consequently increase HIV replication, <clueType>leading</clueType> <linkTheme>to</linkTheme> an increase in the cytopathic effect <clueLoc>on coinfected human T cells</clueLoc>.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
